SCHEMBL4173953

SCHEMBL4173953

CCOC(=O)c1c(C(C)C)[nH]c(-c2ccc(F)cc2)c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 4/20 0.49
TP53 P04637 2/20 0.49
ALDH1A1 P00352 6/20 0.47
MAPT P10636 6/20 0.47
HPGD P15428 4/20 0.47
KDM4E B2RXH2 3/20 0.47
GAA P10253 3/20 0.47
NPSR1 Q6W5P4 3/20 0.47
LMNA P02545 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MAPK10 P53779 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GPR55 Q9Y2T6 2/20 0.44
CHEK1 O14757 1/20 0.44
EGFR P00533 1/20 0.44
KDR P35968 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5804954 0.87 GCGR (0.49) TP53ALDH1A1MAPTHPGDGAA
SCHEMBL4163228 0.84 PTGS2 (0.40) ALDH1A1MAPTKDM4ERAB9AMEN1
SCHEMBL2648462 0.82 GRM6 (0.44) ALDH1A1MAPTHPGDKDM4EGAA
SCHEMBL2662802 0.82 MAPK14 (0.55) MDM2TP53ALDH1A1MAPTHPGD
SCHEMBL2662901 0.81 GRM6 (0.46) MDM2TP53ALDH1A1MAPTHPGD
SCHEMBL5821884 0.81 RAB9A (0.45) MDM2TP53ALDH1A1MAPTHPGD
SCHEMBL1126493 0.81 MAPT (0.53) ALDH1A1MAPTHPGDKDM4EGAA
SCHEMBL17309573 0.81 MAPK14 (0.41) ALDH1A1MAPTKDM4EGAARAB9A
SCHEMBL9152019 0.79 GCGR (0.46) TP53ALDH1A1MAPTHPGDKDM4E
SCHEMBL9664732 0.79 GCGR (0.48) MDM2TP53ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009084827-A2 SYNTHETIC INTERMEDIATES, PROCESS FOR PREPARING PYRROLYLHEPTANOIC ACID DERIVATIVES THEREFROM DONG-A PHARM.CO., LTD. (KR) 2009-07-09 WO disclosed
WO-2007107276-A2 PROCESS FOR PREPARING C7 INTERMEDIATES AND THEIR USE IN THE PREPARATION OF N-SUBSTITUTED PYRROLE DERIVATIVES RATIOPHARM GMBH (DE) 2007-09-27 WO disclosed
EP-1834944-A1 Process for preparing C7 intermediates and their use in the preparation on N-substituted pyrrole derivatives Ratiopharm GmbH (DE) 2007-09-19 EP disclosed